Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors

Clinical trial NCT02318329 · COMPLETED

Trial details

NCT number: NCT02318329
Sponsor: Five Prime Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Gastric Cancer Transitional Cell Carcinoma of the Bladder

Start date: 2014-11-01
Primary completion: 2019-02-28
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.